Trial Profile
Safety and efficacy of nilotinib and dasatinib in patients with chronic myeloid leukemia chronic phase
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2016 New trial record